Portal vein thrombosis in Egyptian patients with liver cirrhosis: Role of methylenetetrahydrofolate reductase C677T gene mutation

Hepatology Research

Volumn 40, Issue 5, 2010, Pages 486-493

  Gabr, Mamdouh Ahmed ^a   Bessa, Sahar Saad El Din ^a   El Zamarani, Enas Arafa ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Genetics; Homocysteine; Liver cirrhosis; Methylenetetrahydrofolate reductase; Portal vein thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALBUMIN; ANTITHROMBIN III; BILIRUBIN; HOMOCYSTEINE; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EGYPT; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; WILD TYPE;

EID: 77954378609     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00628.x     Document Type: Article

References (46)

1. Okuda K, Ohnishi K, Kimura K. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985, 89:279-86.
2. Fimognari FL, Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 2008, 3:213-18.
3. Janssen HL, Wijnhoud A, Haagsma EB. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001, 49:720-4.
4. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000, 32:865-71.
5. Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int 2005, 4:515-18.
6. Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterol 2002, 97:535-41.
7. Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 2005, 21:1-9.
8. Amitrano L, Guardascione MA, Ames PR. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clin Lab 2007, 53:583-9.
9. Madonna P, De Stefano V, Coppola A, Cerbone AM, Di Minno G. G20210A prothrombin gene mutation and other thrombophilic polymorphisms in patients with portal or hepatic venous thrombosis. Gastroenterology 2001, 120:1059-67.
10. Walker AP. Portal vein thrombosis: what is the role of genetics. Eur J Gastroenterol Hepatol 2005, 17:705-7.
11. Miner SE, Evrovski J, Cole DE. Clinical chemistry and molecular biology of homocysteine metabolism: an update. Clin Biochem 1997, 30:189-201.
12. Medina MA, Amores-sanchez MI. Genetic basis of hyperhomocysteinemia. Mol Genet Metab 2000, 71:478-80.
13. Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000, 13:20-33.
14. Frosst P, Blom HJ, Milos R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-13.
15. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001, 22:195-201.
16. Cortese C, Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr 2001, 4:493-7.
17. Lim PS, Hung WR, Wei YH. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis. Nephron 2001, 87:249-56.
18. Arai K, Yamasaki Y, Kajimoto Y. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM. Diabetes 1997, 46:2102-4.
19. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MG, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-9.
20. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996, 143:1257-65.
21. Silver HK, Gold P, Feder S, Freedman SO, Shuster J. Radioimmunoassay for human alpha1- fetoprotein. Proc Nat Acad Sci USA 1973, 70:526-30.
22. Mangia A, Vallari D, Di Bisceglie AM. Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma. J Med Virol 1994, 43:125-8.
23. Frantzen F, Faaren AL, Alfheim I, Nordhei AK. An enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 1998, 44:311-16.
24. Martinez HR, Rangel-Guerra RA, Marfil LJ. Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993, 24:19-25.
25. Jacques PF, Bostom AG, Williams RR. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93:7-9.
26. Ögren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23796 consecutive autopsies. World J Gastroenterol 2006, 12:2115-19.
27. Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies. Pathophysiol Haemost Thromb 2002, 32:51-8.
28. den Heijer M, Keijzer MB. Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med 2001, 39:710-13.
29. Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 1998, 158:2101-6.
30. Margaglione M, D'Andrea G, d'Addedda M. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost 1998, 79:907-11.
31. Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med 2007, 131:872-84.
32. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 2005, 6:27-36.
33. Pasta L, Marrone C, D'Amico M. MTHFR C677T mutations in liver cirrhosis with and without portal vein thrombosis. Liver Int 2006, 26:269-70.
34. Amitrano L, Brancaccio V, Guardascione MA. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000, 31:345-8.
35. Hotoleanu C, Andercou O, Andercou A. Mesenteric venous thrombosis with bowel infarction and hyperhomocysteinemia due to homozygous methylenetetrahydrofolate reductase C677T genotype. Vasc Endovasc Surg 2008, 42:477-81.
36. Elhajj II, Salem ZM, Birjawi GA, Taher AT, Soweid AM. Heterozygous prothrombin 20210G/A mutation, associated with hyperhomocysteinemia, and homozygous methylenetetrahydrofolate reductase 677 C/T mutation, in a patient with portal and mesenteric venous thrombosis. Hematol J 2004, 5:540-2.
37. Svehlová M, Stepánková L, Kaupeová P, Sykora J. Portal vein thrombosis in a patient with hyperhomocysteinemia. Vnitr Lek 2002, 48:671-4.
38. Amitrano L, Brancaccio V, Guardascione MA. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002, 34:535-8.
39. Fabris C, Toniutto P, Falleti E. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Alcohol Clin Exp Res 2009, 33:102-7.
40. Akoglu B, Kindl P, Weber N, Trojan J, Caspary WF, Faust D. The C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR) and consecutive hyperhomocysteinemia are responsible for vascular complications after liver transplantation. Hepatology 2005, 42(1):329A. Suppl
41. Mangia A, Villani MR, Cappucci G. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005, 17:745-51.
42. Erkan O, Bozdayi AM, Disibeyaz S. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 2005, 17:339-43.
43. Amitrano L, Guardascione MA, Brancaccio V. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004, 40:736-41.
44. Tan KJ, Chow PK, Tan YM, Thng CH. Portal vein thrombosis secondary to hyperhomocysteinemia: a case report. Dig Dis Sci 2006, 51:1218-20.
45. Dworakowska D, Kazimierska E, Weyer-Hepka J. Hyperhomocysteinemia complicated by myocardial infarction and portal vein thrombosis-case report. Pol Arch Med Wewn 2006, 115:234-7.
46. Audemar F, Denis B, Blaison G, Mazurier I, Peter A, Serbout R. Left branch portal vein thrombosis associated with hyperhomocysteinemia. Gastroenterol Clin Biol 1999, 23:1388-91.